TYPE 1 DIABETES MELLITUS
Clinical trials for TYPE 1 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new TYPE 1 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for TYPE 1 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common cholesterol pill save sight in type 1 diabetes?
Disease control OngoingThis study tests whether a daily pill called fenofibrate can slow or prevent worsening eye disease (diabetic retinopathy) in adults with type 1 diabetes. About 412 participants with early eye damage are taking either the drug or a placebo for several years. The goal is to see if …
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE3 • Sponsor: University of Sydney • Aim: Disease control
Last updated May 17, 2026 04:36 UTC
-
App aims to simplify insulin dosing for type 1 diabetes patients
Disease control OngoingThis study tests whether a smartphone app called Diabetes M helps people with type 1 diabetes calculate their insulin doses more accurately than their usual method. Thirty adults will use the app for two weeks and compare their blood sugar control to two weeks without it. The goa…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Medical University of Sofia • Aim: Disease control
Last updated May 17, 2026 04:35 UTC
-
New shot aims to save Insulin-Making cells in type 1 diabetes
Disease control OngoingThis study tests a treatment called Diamyd in people aged 12 to 29 who were recently diagnosed with type 1 diabetes and have a specific genetic marker. The goal is to see if it can help preserve the body's ability to produce insulin, which may lead to better blood sugar control. …
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE3 • Sponsor: Diamyd Medical AB • Aim: Disease control
Last updated May 17, 2026 04:32 UTC
-
New drug aims to keep insulin cells working longer in type 1 diabetes
Disease control OngoingThis study tests a new drug called brivekimig in people recently diagnosed with type 1 diabetes. The goal is to see if it can help preserve the body's ability to make some insulin, reducing the need for injected insulin. About 84 adults and adolescents will receive either the dru…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 17, 2026 04:30 UTC
-
Smart pump trial aims to tame tough diabetes cases
Disease control OngoingThis study tests a hybrid closed-loop insulin pump system (mylife CamAPS FX) in 30 adults with type 1 diabetes who have chronically high blood sugar and psychological challenges. Participants either start the pump immediately or after a 3-month delay. The goal is to see if the sy…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Jerzy Hohendorff • Aim: Disease control
Last updated May 17, 2026 04:30 UTC
-
Could probiotics tame type 1 diabetes inflammation?
Disease control OngoingThis study tests whether a daily probiotic supplement can reduce inflammation in children and teens newly diagnosed with type 1 diabetes. Researchers believe that changes in gut bacteria may worsen the disease. Participants take either the probiotic or a placebo for several month…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 17, 2026 04:29 UTC
-
Islet transplants aim to free type 1 diabetics from severe lows
Disease control OngoingThis phase 3 trial tests whether transplanting insulin-producing cells (islets) from donors can help adults with type 1 diabetes who still have dangerous low blood sugar episodes despite intensive insulin therapy. The goal is to improve blood sugar control and eliminate severe hy…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE3 • Sponsor: CellTrans Inc. • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
Could a custom vaccine teach the immune system to stop attacking the pancreas?
Disease control OngoingThis early-phase study tests a new vaccine made from a person's own immune cells and a small piece of insulin protein. The goal is to see if it is safe and possible to teach the immune system to stop destroying the pancreas cells that make insulin. Six adults with type 1 diabetes…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
Two-Drug cocktail may slow type 1 diabetes progression
Disease control OngoingThis study tests whether giving two immune-calming drugs, rituximab followed by abatacept, can help people newly diagnosed with type 1 diabetes keep making their own insulin longer than rituximab alone. About 74 participants aged 8 to 45 will receive the combo or a placebo over 4…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Implantable 'Cell Pouch' could free diabetics from insulin shots?
Disease control OngoingThis study tests a device called the Cell Pouch, which is implanted in the abdomen to house insulin-producing cells for people with Type 1 Diabetes who have dangerous low blood sugar episodes. The goal is to see if the device is safe and can help the cells survive long-term, pote…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: Sernova Biotherapeutics Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New islet transplant could free some from insulin shots
Disease control OngoingThis study tests if transplanting insulin-making cells from donors can help people with type 1 diabetes control blood sugar better and possibly stop insulin shots. Participants get anti-rejection drugs to protect the new cells. Up to 10 people will be followed for 5 years to see …
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Massage and yoga battle to lower Kids' blood sugar
Disease control OngoingThis study looks at whether Swedish massage or yoga can help lower blood sugar levels in children aged 6 to 12 with type 1 diabetes. Both techniques are relaxing and may reduce stress, which can help control blood sugar. The study involves 50 children from Cairo who do not have o…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Al-Zaytoonah University of Jordan • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
Probiotic shows promise in slowing type 1 diabetes progression
Disease control OngoingThis study tests whether a probiotic called Lactiplantibacillus plantarum 299v can reduce inflammation and help preserve the body's ability to produce insulin in people recently diagnosed with type 1 diabetes. About 60 participants aged 3 to 45 will take the probiotic or a placeb…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
Decades-Long diabetes study reveals lasting benefits of early intensive treatment
Knowledge-focused OngoingThis study follows over 1,400 people with type 1 diabetes who were part of an earlier trial comparing intensive versus standard blood sugar control. Researchers are tracking long-term health issues like eye, kidney, nerve, and heart problems, as well as physical and mental declin…
Matched conditions: TYPE 1 DIABETES MELLITUS
Sponsor: George Washington University • Aim: Knowledge-focused
Last updated May 17, 2026 04:14 UTC
-
Can a healthier lifestyle rewrite sperm DNA?
Knowledge-focused OngoingThis study looks at whether being overweight or having diabetes changes certain chemical marks on sperm DNA. Researchers will check if a 3-month lifestyle or blood sugar program can improve these marks. The study involves 40 men aged 18-65 who are overweight, with or without diab…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC